# Spaceflight Thymus Transcriptomics: Multi-Graph Analysis of OSD-244 (Rodent Research-6)

## Chat Transcript

---

👤 **User**

`@spoke-genelab`: describe the Assay node and its relationships

---

🧠 **Assistant**

The **Assay** node in `spoke-genelab` represents a unique assay instance from NASA's Open Science Data Repository (OSDR). It sits at the center of the graph, connecting experimental procedures to biological entities and measurements.

**Incoming relationship** — one edge points *into* Assay:

- `PERFORMED_SpAS` from **Study**: a study performs one or more assays.

**Outgoing relationships** — five edges radiate *out* from Assay:

- `INVESTIGATED_ASiA` → **Anatomy**: links the assay to the UBERON anatomical entity it examined.
- `INVESTIGATED_ASiCT` → **CellType**: links to the Cell Ontology class examined.
- `MEASURED_DIFFERENTIAL_EXPRESSION_ASmMG` → **Gene**: captures differential gene expression results, with edge properties `log2fc`, `adj_p_value`, `group_mean_1/2`, and `group_stdev_1/2`.
- `MEASURED_DIFFERENTIAL_ABUNDANCE_ASmO` → **Organism**: captures differential microbial abundance, adding `lnfc` and `q_value`.
- `MEASURED_DIFFERENTIAL_METHYLATION_ASmMR` → **MethylationRegion**: captures differential methylation in 1 kb genomic windows, with `methylation_diff` and `q_value`.

**Assay node properties** include `measurement`, `technology`, `factor_space_1/2`, `factors_1/2`, and `material_1/2` / `material_name_1/2` / `material_id_1/2`.

```mermaid
graph TD
    S["Study<br/><small>OSDR study ID</small>"] -->|PERFORMED_SpAS| A["Assay<br/><small>OSDR assay instance</small>"]
    A -->|INVESTIGATED_ASiA| AN["Anatomy<br/><small>UBERON entity</small>"]
    A -->|INVESTIGATED_ASiCT| CT["CellType<br/><small>Cell ontology class</small>"]
    A -->|"MEASURED_DIFFERENTIAL<br/>_EXPRESSION_ASmMG"| G["Gene<br/><small>ENTREZ gene ID</small>"]
    A -->|"MEASURED_DIFFERENTIAL<br/>_ABUNDANCE_ASmO"| O["Organism<br/><small>Microbial taxon ID</small>"]
    A -->|"MEASURED_DIFFERENTIAL<br/>_METHYLATION_ASmMR"| MR["MethylationRegion<br/><small>1kb genomic region</small>"]

    style S fill:#E1F5EE,stroke:#0F6E56
    style A fill:#EEEDFE,stroke:#534AB7
    style AN fill:#FAECE7,stroke:#993C1D
    style CT fill:#FBEAF0,stroke:#993556
    style G fill:#E6F1FB,stroke:#185FA5
    style O fill:#EAF3DE,stroke:#3B6D11
    style MR fill:#FAEEDA,stroke:#854F0B
```

---

👤 **User**

`@spoke-genelab`: Get information about study OSD-244 and draw a diagram of the assay conditions

---

🧠 **Assistant**

**Study OSD-244 (Rodent Research-6)** is a spaceflight study that launched 40 female C57BL/6NTac mice on SpaceX-13 in December 2017 to evaluate muscle atrophy in microgravity and test the therapeutic formoterol. GeneLab received thymus tissue from sham-treated animals only and performed RNA-Seq (Illumina NovaSeq 6000, ribodepleted, paired-end 150bp).

The graph contains **30 distinct assay nodes** for this study, all measuring transcription profiling on thymus. Each assay represents a **pairwise differential expression comparison** between combinations of three experimental arms and multiple processing/timepoint factors.

```mermaid
graph TD
    subgraph Study
        OSD["OSD-244: Rodent Research-6<br/><small>Mus musculus | Spaceflight Study | SpaceX-13</small>"]
    end

    OSD --> RNA["RNA-Seq transcription profiling<br/><small>Illumina NovaSeq 6000 | thymus | 30 assay nodes</small>"]

    RNA --> SF["Space Flight<br/><small>ISS microgravity</small>"]
    RNA --> GC["Ground Control<br/><small>KSC mimicked conditions</small>"]
    RNA --> BC["Basal Control<br/><small>Baseline sacrifice</small>"]

    SF <-->|compared| GC
    GC <-->|compared| BC

    subgraph Timepoints
        T1["LAR ~30 day"]
        T2["ISS Terminal ~60 day"]
        T3["Carcass"]
        T4["Upon euthanasia"]
        T5["On ISS / On Earth"]
        T6["1 day"]
    end

    style OSD fill:#E1F5EE,stroke:#0F6E56
    style RNA fill:#EEEDFE,stroke:#534AB7
    style SF fill:#FAECE7,stroke:#993C1D
    style GC fill:#E6F1FB,stroke:#185FA5
    style BC fill:#FAEEDA,stroke:#854F0B
```

**Three experimental arms**: Space Flight (ISS microgravity), Ground Control (mimicked conditions at KSC), and Basal Control (baseline sacrifice groups).

**Timepoints and processing factors**: ~30 day (LAR, live animal return), ~60 day (ISS Terminal, on-orbit dissection), 1 day, Upon euthanasia, On ISS, On Earth, and Carcass.

The 30 assay nodes collectively represent 480 factor-pair combinations spanning all pairwise comparisons across these conditions.

---

👤 **User**

Find the assays that compare Space Flight vs. Ground Control at the 30 day and 60 day time points. Include all other factors for each assay such as sample collection conditions.

---

🧠 **Assistant**

I found **4 assay nodes** in OSD-244 that compare Space Flight vs Ground Control and involve the ~30 day or ~60 day timepoints:

| # | Assay ID | Group 1 (Space Flight) | Group 2 (Ground Control) | Description |
|---|----------|----------------------|------------------------|-------------|
| 1 | `OSD-244-57da8b7c…` | Space Flight, ~30 day, Upon euthanasia, On Earth | Ground Control, ~30 day, Upon euthanasia, On Earth | **LAR ~30 day matched** |
| 2 | `OSD-244-fcfe5c9b…` | Space Flight, ~30 day, Upon euthanasia, On Earth | Ground Control, ~60 day, Carcass, On Earth | **LAR ~30 day flight vs ISS Terminal ~60 day ground** |
| 3 | `OSD-244-adb98a42…` | Space Flight, ~60 day, Carcass, On ISS | Ground Control, ~30 day, Upon euthanasia, On Earth | **ISS Terminal ~60 day flight vs ~30 day ground** |
| 4 | `OSD-244-0a77ea7b…` | Space Flight, ~60 day, Carcass, On ISS | Ground Control, ~60 day, Carcass, On Earth | **ISS Terminal ~60 day matched** |

All assays: Tissue = **thymus** | Method = **DESeq2** | Platform = **Illumina NovaSeq 6000** | RNA-Seq

**Assay 1** and **Assay 4** are the cleanest matched-timepoint comparisons. **Assay 2** and **Assay 3** are cross-timepoint comparisons. The LAR groups were processed `Upon euthanasia` after live return to Earth, while the ISS Terminal flight group was processed as `Carcass` tissue `On ISS`.

---

👤 **User**

Find the top 10 differentially up- and downregulated genes for Space Flight → Ground Control ~30 day

---

🧠 **Assistant**

Results from the ~30 day matched-timepoint assay (`OSD-244-57da8b7c…`), adj p-value ≤ 0.05:

### Top 10 Upregulated Genes (~30 day)

| Gene | log2FC | adj p-value | Mean Flight / Ground |
|------|--------|-------------|---------------------|
| **Trav7d-2** | +20.53 | 7.99e-3 | 8.18 / 1.00 |
| **Sftpc** | +9.37 | 6.31e-3 | 6662 / 11.0 |
| **Cldn18** | +6.77 | 1.14e-2 | 405 / 4.78 |
| **Sftpb** | +6.77 | 1.04e-2 | 1815 / 17.6 |
| **Cxcl15** | +6.35 | 1.63e-2 | 623 / 8.67 |
| **Slc34a2** | +5.13 | 7.09e-3 | 2087 / 60.6 |
| **Prss27** | +5.01 | 4.99e-3 | 39.1 / 29.6 |
| **Dbh** | +4.99 | 9.62e-3 | 31.8 / 278 |
| **Ly6g6c** | +4.34 | 1.15e-2 | 97.0 / 97.4 |
| **Lamp3** | +4.29 | 1.16e-2 | 438 / 23.5 |

### Top 10 Downregulated Genes (~30 day)

| Gene | log2FC | adj p-value | Mean Flight / Ground |
|------|--------|-------------|---------------------|
| **Cnfn** | -15.76 | 7.99e-3 | 145 / 170 |
| **Cldn34c6** | -6.64 | 3.48e-2 | 1.09 / 18.1 |
| **Gpr101** | -6.54 | 8.62e-3 | 1.09 / 17.1 |
| **Vmn1r28** | -6.27 | 3.28e-2 | 1.07 / 14.8 |
| **Vmn2r94** | -6.25 | 4.09e-2 | 1.30 / 19.0 |
| **Gm14052** | -6.20 | 2.96e-2 | 1.00 / 10.6 |
| **A630073D07Rik** | -6.19 | 1.68e-2 | 1.47 / 28.4 |
| **Olfr1489** | -6.13 | 2.79e-2 | 1.17 / 19.3 |
| **Vmn2r66** | -6.01 | 8.93e-3 | 1.19 / 15.9 |
| **Olfr613** | -6.00 | 1.57e-2 | 1.00 / 9.52 |

The upregulated genes are dominated by lung-associated markers (Sftpc, Sftpb, Cldn18, Slc34a2, Cxcl15, Lamp3). The downregulated list is enriched for olfactory and vomeronasal receptor genes with very low baseline expression.

---

👤 **User**

Find the top 10 differentially up- and downregulated genes for Space Flight → Ground Control ~60 day

---

🧠 **Assistant**

Results from the ~60 day matched-timepoint assay (`OSD-244-0a77ea7b…`), adj p-value ≤ 0.05:

### Top 10 Upregulated Genes (~60 day)

| Gene | log2FC | adj p-value | Mean Flight / Ground |
|------|--------|-------------|---------------------|
| **Krt4** | +9.43 | 1.20e-8 | 3857 / 2.95 |
| **Myh8** | +8.66 | 1.93e-6 | 12587 / 8.73 |
| **Krt13** | +8.25 | 1.66e-7 | 2541 / 4.35 |
| **Klk11** | +6.74 | 5.10e-3 | 33.3 / 1.28 |
| **Cfap97d2** | +6.59 | 2.65e-4 | 23.0 / 1.05 |
| **Bpifa1** | +6.32 | 1.01e-4 | 28061 / 353 |
| **Bpifb1** | +6.07 | 3.04e-3 | 896 / 14.3 |
| **Gm36041** | +5.95 | 1.78e-3 | 48.8 / 1.75 |
| **Scgb3a1** | +5.94 | 1.24e-3 | 1806 / 30.5 |
| **C730027H18Rik** | +5.84 | 3.27e-3 | 16.9 / 1.05 |

### Top 10 Downregulated Genes (~60 day)

| Gene | log2FC | adj p-value | Mean Flight / Ground |
|------|--------|-------------|---------------------|
| **Ibsp** | -7.21 | 3.48e-5 | 1.47 / 73.7 |
| **Gm25682** | -6.12 | 5.89e-3 | 1.32 / 25.5 |
| **Gm23686** | -5.31 | 1.24e-3 | 5.35 / 173 |
| **Gm25189** | -4.98 | 3.36e-2 | 2.92 / 61.4 |
| **Gm23511** | -3.28 | 4.27e-2 | 4.07 / 30.7 |
| **Dynlt2a3** | -3.27 | 3.16e-2 | 1.39 / 5.31 |
| **Kcnh7** | -3.25 | 5.53e-3 | 2.13 / 12.3 |
| **Tnn** | -3.13 | 1.77e-2 | 9.79 / 78.0 |
| **Bglap** | -2.83 | 1.53e-2 | 3.38 / 17.7 |
| **Tnni1** | -2.60 | 2.77e-2 | 10.2 / 56.6 |

The ~60 day results show clearer biological signatures: epithelial keratins and secretory proteins upregulated, bone resorption markers (`Ibsp`, `Bglap`) downregulated — consistent with longer microgravity exposure producing more pronounced physiological changes in the thymus.

---

👤 **User**

Find the common significantly differentially expressed genes for the ~30 day and ~60 duration time points and create a concordance diagram for these genes.

---

🧠 **Assistant**

### Overlap Summary

| Set | Count |
|-----|-------|
| ~30 day DEGs (adj p ≤ 0.05) | 3,597 |
| ~60 day DEGs (adj p ≤ 0.05) | 1,699 |
| **Common DEGs** | **322** |
| Concordant upregulated (both +) | 242 |
| Concordant downregulated (both −) | 75 |
| Discordant (opposite signs) | 5 |

```mermaid
graph LR
    subgraph "~30 day only"
        A["3,275 genes"]
    end
    subgraph "Common: 322"
        B["242 up ↑↑<br/>75 down ↓↓<br/>5 discordant ↑↓"]
    end
    subgraph "~60 day only"
        C["1,377 genes"]
    end
    A --- B --- C

    style A fill:#EEEDFE,stroke:#534AB7
    style B fill:#FAEEDA,stroke:#854F0B
    style C fill:#E6F1FB,stroke:#185FA5
```

![Concordance: OSD-244 Assay](https://github.com/sbl-sdsc/mcp-proto-okn/blob/main/docs/examples/concordance_scatter_30d_vs_60d.png)

### Top 15 Concordant Upregulated Genes

| Gene | 30d log2FC | 60d log2FC | 30d p-value | 60d p-value |
|------|-----------|-----------|-------------|-------------|
| **Sim2** | +3.53 | +5.60 | 4.25e-2 | 2.41e-4 |
| **Ly6g6c** | +4.34 | +4.58 | 1.15e-2 | 5.57e-3 |
| **Agt** | +3.85 | +4.44 | 7.99e-3 | 2.01e-5 |
| **Ceacam19** | +3.30 | +4.08 | 3.51e-2 | 9.63e-3 |
| **F10** | +3.50 | +3.81 | 6.57e-3 | 1.87e-5 |
| **Hmga1b** | +3.22 | +3.87 | 4.15e-2 | 6.63e-3 |
| **Clca1** | +3.39 | +3.53 | 2.53e-2 | 1.19e-2 |
| **Alox15** | +3.01 | +3.83 | 6.65e-3 | 8.31e-7 |
| **F7** | +3.37 | +3.40 | 1.81e-2 | 5.10e-3 |
| **Ahsg** | +3.19 | +3.56 | 2.54e-2 | 4.35e-3 |
| **Prkag3** | +3.07 | +3.11 | 1.96e-2 | 8.56e-3 |
| **Gsc** | +2.88 | +3.26 | 3.42e-2 | 1.63e-2 |
| **Hamp** | +3.17 | +2.85 | 2.47e-2 | 2.84e-2 |
| **Asb5** | +3.01 | +2.98 | 4.59e-2 | 3.69e-2 |
| **Igkv17-121** | +2.44 | +3.52 | 1.94e-2 | 3.60e-5 |

### Top 15 Concordant Downregulated Genes

| Gene | 30d log2FC | 60d log2FC | 30d p-value | 60d p-value |
|------|-----------|-----------|-------------|-------------|
| **Kcnh7** | -2.55 | -3.25 | 2.68e-2 | 5.53e-3 |
| **Gm24871** | -2.10 | -1.97 | 9.62e-3 | 4.33e-3 |
| **Gm33619** | -2.11 | -1.73 | 1.98e-2 | 4.16e-2 |
| **2310015K22Rik** | -1.86 | -1.75 | 2.63e-2 | 2.47e-2 |
| **Gm22488** | -1.84 | -1.70 | 3.10e-2 | 2.95e-2 |
| **Gm24451** | -1.92 | -1.58 | 2.47e-2 | 4.33e-2 |
| **Rnu12** | -1.89 | -1.61 | 2.11e-2 | 3.40e-2 |
| **Gm12238** | -2.11 | -1.32 | 2.92e-2 | 2.63e-2 |
| **Snora36b** | -1.82 | -1.58 | 4.68e-2 | 4.94e-2 |
| **Gm25313** | -1.75 | -1.63 | 3.54e-2 | 3.69e-2 |
| **Trbv23** | -1.67 | -1.47 | 2.54e-2 | 3.44e-2 |
| **Gm39792** | -1.71 | -1.41 | 1.87e-2 | 3.95e-2 |
| **Itm2a** | -1.88 | -1.16 | 6.31e-3 | 3.12e-2 |
| **Gm26130** | -1.61 | -1.42 | 2.39e-2 | 3.25e-2 |
| **Nebl** | -1.72 | -1.23 | 8.62e-3 | 3.26e-2 |

### All 5 Discordant Genes (down at ~30d → up at ~60d)

| Gene | 30d log2FC | 60d log2FC |
|------|-----------|-----------|
| **Gm39079** | -4.36 | +3.71 |
| **Albfm1** | -4.01 | +3.44 |
| **Tmem45a2** | -4.01 | +3.05 |
| **Gm10319** | -3.23 | +2.95 |
| **Mgam** | -1.33 | +1.37 |

The concordance is remarkably high — 98.4% (317/322) show the same direction of change.

---

👤 **User**

`@spoke-genelab`: Map the mouse genes to the human orthologs

---

🧠 **Assistant**

Using the `IS_ORTHOLOG_MGiG` relationship in spoke-genelab, I mapped the 35 mouse genes from the concordance set to their human orthologs. Of these, **27 mapped to human orthologs** and **22 had named human gene symbols**.

### Mouse → Human Ortholog Mapping (Concordant Upregulated)

| Mouse Gene | Human Ortholog | 30d log2FC | 60d log2FC |
|-----------|---------------|-----------|-----------|
| Sim2 | **SIM2** (NCBI 6493) | +3.53 | +5.60 |
| Ly6g6c | **LY6G6C** (NCBI 80740) | +4.34 | +4.58 |
| Agt | **AGT** (NCBI 183) | +3.85 | +4.44 |
| Ceacam19 | **CEACAM19** (NCBI 56971) | +3.30 | +4.08 |
| F10 | **F10** (NCBI 2159) | +3.50 | +3.81 |
| Hmga1b | **HMGA1** (NCBI 3159) | +3.22 | +3.87 |
| Alox15 | **ALOX15** (NCBI 246) | +3.01 | +3.83 |
| Clca1 | **CLCA1** (NCBI 1179) | +3.39 | +3.53 |
| F7 | **F7** (NCBI 2155) | +3.37 | +3.40 |
| Ahsg | **AHSG** (NCBI 197) | +3.19 | +3.56 |
| Prkag3 | **PRKAG3** (NCBI 53632) | +3.07 | +3.11 |
| Gsc | **GSC** (NCBI 145258) | +2.88 | +3.26 |
| Hamp | **HAMP** (NCBI 57817) | +3.17 | +2.85 |
| Asb5 | **ASB5** (NCBI 140458) | +3.01 | +2.98 |

### Mouse → Human Ortholog Mapping (Concordant Downregulated)

| Mouse Gene | Human Ortholog | 30d log2FC | 60d log2FC |
|-----------|---------------|-----------|-----------|
| Kcnh7 | **KCNH7** (NCBI 90134) | -2.55 | -3.25 |
| Gm24871 | **RNU5E-1** (NCBI 26829) | -2.10 | -1.97 |
| Gm25313 | **RNU5B-1** (NCBI 26832) | -1.75 | -1.63 |
| Rnu12 | **RNU12** (NCBI 267010) | -1.89 | -1.61 |
| Itm2a | **ITM2A** (NCBI 9452) | -1.88 | -1.16 |
| Nebl | **NEBL** (NCBI 10529) | -1.72 | -1.23 |

### Discordant Genes with Human Orthologs

| Mouse Gene | Human Ortholog | 30d log2FC | 60d log2FC |
|-----------|---------------|-----------|-----------|
| Tmem45a2 | **TMEM45A** (NCBI 55076) | -4.01 | +3.05 |
| Mgam | **MGAM** (NCBI 8972) | -1.33 | +1.37 |

### Genes Without Ortholog in Graph (8 total)
2310015K22Rik, Albfm1, Gm10319, Gm12238, Gm24451, Gm33619, Gm39079, Gm39792

---

👤 **User**

`@spoke-okn`: Which diseases are associated with these genes?

---

🧠 **Assistant**

Cross-graph query bridging spoke-genelab mouse genes → human orthologs → spoke-okn disease associations via the `ASSOCIATES_DaG`, `EXPRESSEDIN_GeiD`, `MARKER_POS_GmpD`, and `MARKER_NEG_GmnD` predicates. spoke-okn uses NCBI Gene IDs directly for gene nodes.

### Summary

| Metric | Count |
|--------|-------|
| Human genes queried | 20 |
| With disease associations | 16 |
| Gene–disease links | 47 |
| Unique diseases | 26 |

### Disease Associations for Concordant Upregulated Genes

| Gene | Disease Associations | Cancer Expression/Markers |
|------|---------------------|-------------------------|
| **AGT** | hypertension, coronary artery disease, cardiomyopathy, arteriosclerosis, cerebrovascular disease, chronic kidney disease, diabetes mellitus, obesity, COVID-19, viral infectious disease, nervous system disease, nutrition disease | expressed in liver cancer |
| **HAMP** | iron deficiency anemia, thalassemia, liver disease, chronic kidney disease, cardiomyopathy, diabetes mellitus | expressed in liver cancer |
| **HMGA1** | diabetes mellitus | **unfavorable** marker: liver, lung, pancreatic cancer |
| **CLCA1** | — | expressed in colorectal & pancreatic cancer; **favorable** marker: colorectal cancer |
| **F10** | — | expressed in liver cancer; **favorable**: pancreatic cancer; **unfavorable**: kidney cancer |
| **F7** | — | expressed in liver cancer |
| **LY6G6C** | hypertension | — |
| **AHSG** | epilepsy | expressed in liver cancer |
| **ALOX15** | — | expressed in cervical cancer |
| **ASB5** | — | expressed in prostate cancer |
| **SIM2** | — | expressed in prostate cancer |

### Disease Associations for Concordant Downregulated Genes

| Gene | Disease Associations | Cancer Expression/Markers |
|------|---------------------|-------------------------|
| **KCNH7** | psoriasis | — |
| **NEBL** | COPD, schizophrenia | **favorable** marker: kidney cancer |
| **ITM2A** | — | **favorable** marker: liver cancer |

### Disease Associations for Discordant Genes

| Gene | Disease Associations | Cancer Expression/Markers |
|------|---------------------|-------------------------|
| **TMEM45A** | — | **unfavorable** marker: kidney cancer, lung cancer |
| **MGAM** | diabetes mellitus | expressed in kidney cancer; **favorable** marker: kidney cancer |

No disease associations found for: CEACAM19, GSC, PRKAG3, RNU12.

**Key finding**: HMGA1 (concordantly upregulated) is an unfavorable marker in 3 cancers, while ITM2A and NEBL (both downregulated) are favorable markers — meaning spaceflight pushes these genes in a prognostically unfavorable direction.

---

👤 **User**

Identify publications that mention these genes in the context of spaceflight or microgravity, and return: PMID, Title, Year, Brief relevance summary (1 sentence)

---

🧠 **Assistant**

### Publications Linking Concordance Genes to Spaceflight / Microgravity

| PMID | Year | Genes | Title | Relevance |
|------|------|-------|-------|-----------|
| [28087888](https://pubmed.ncbi.nlm.nih.gov/28087888/) | 2017 | HAMP | Simulated microgravity decreases circulating iron in rats: role of inflammation-induced hepcidin upregulation | Directly demonstrates that hindlimb unloading upregulates hepatic hepcidin (Hamp) via IL-6/STAT3 inflammatory signaling, decreasing circulating iron in rats. |
| [35025886](https://pubmed.ncbi.nlm.nih.gov/35025886/) | 2022 | HAMP | Hemolysis contributes to anemia during long-duration space flight | Reports persistent hemolysis in 14 astronauts over 6-month ISS missions, with elevated iron markers implicating hepcidin-regulated iron redistribution in space anemia. |
| [32943636](https://pubmed.ncbi.nlm.nih.gov/32943636/) | 2020 | HAMP | Simulated microgravity disturbs iron metabolism and distribution in humans: lessons from dry immersion | Shows significant hepcidin elevation and spleen iron sequestration in humans during 3-day dry immersion simulating microgravity. |
| [19060235](https://pubmed.ncbi.nlm.nih.gov/19060235/) | 2009 | AGT, ITM2A | Spaceflight effects on T lymphocyte distribution, function and gene expression | Directly analyzed thymus gene expression in mice after STS-118 spaceflight, reporting 30 of 84 cancer-related genes significantly altered. |
| [32054867](https://pubmed.ncbi.nlm.nih.gov/32054867/) | 2020 | AGT, HAMP, AHSG, F7, F10 | Validation of a new rodent experimental system to investigate consequences of long duration space habitation | NASA RR-1 validation showing thymus weight changes after 37 days of ISS microgravity, relevant to hepatic-origin genes found in RR-6 thymus. |
| [28725744](https://pubmed.ncbi.nlm.nih.gov/28725744/) | 2016 | HMGA1 | Spaceflight modulates gene expression in the whole blood of astronauts | First transcriptomic assessment of astronaut whole blood showing differential regulation of stress-response and chromatin remodeling pathways. |
| [37048115](https://pubmed.ncbi.nlm.nih.gov/37048115/) | 2023 | HMGA1, ALOX15, KCNH7 | Current knowledge about the impact of microgravity on gene regulation | Comprehensive review covering microgravity-induced gene regulation changes across immune, bone, muscle, and cancer contexts. |
| [32424225](https://pubmed.ncbi.nlm.nih.gov/32424225/) | 2020 | ALOX15 | Lipid signalling in human immune response and bone remodelling under microgravity | Reviews LOX pathway alterations under microgravity, showing 15-LOX (ALOX15) affected by weightlessness in immune and bone contexts. |
| [38658683](https://pubmed.ncbi.nlm.nih.gov/38658683/) | 2024 | ALOX15 | Cellular and molecular effects of microgravity on the immune system: a focus on bioactive lipids | Demonstrates LOX catalytic activity is altered by microgravity, implicating the arachidonate lipoxygenase family in spaceflight immune dysregulation. |
| [37912840](https://pubmed.ncbi.nlm.nih.gov/37912840/) | 2023 | CLCA1, SIM2, NEBL | Single-cell analysis identifies conserved features of immune dysfunction in simulated microgravity and spaceflight | Single-cell profiling validated against ISS data, revealing conserved immune pathway changes including IL-6 and cytoskeleton alterations. |
| [36070701](https://pubmed.ncbi.nlm.nih.gov/36070701/) | 2022 | AGT, HAMP, AHSG | Exploring the effects of spaceflight on mouse physiology using the open access NASA GeneLab platform | Describes how GeneLab rodent data revealed transcriptome-wide hypoxic response signatures in ISS Rodent Habitats. |
| [39557481](https://pubmed.ncbi.nlm.nih.gov/39557481/) | 2025 | HAMP | Ferroptosis in space: how microgravity alters iron homeostasis | Reviews iron-dependent ferroptosis under microgravity, highlighting hepcidin dysregulation triggering oxidative stress. |
| [30688299](https://pubmed.ncbi.nlm.nih.gov/30688299/) | 2019 | AGT, F7, F10, AHSG | Exploring the effects of spaceflight on mouse physiology using the open access NASA GeneLab platform | Methodology for GeneLab analysis showing Rodent Habitat CO₂ conditions affect transcriptomes, potentially explaining ectopic hepatic gene signatures. |

**Note**: No publication was found specifically analyzing these genes in the RR-6 (OSD-244) thymus dataset, suggesting the data deposited in NASA's Open Science Data Repository has not yet been fully analyzed in a primary research publication.

---

### Knowledge Graphs Used

| Graph | Role |
|-------|------|
| `spoke-genelab` | Source of OSD-244 study metadata, assay conditions, differential gene expression data, and mouse-human ortholog mappings |
| `gene-expression-atlas-okn` | Bridge graph providing NCBI Gene ID → Ensembl ID conversion (ultimately not needed as spoke-okn uses NCBI IDs directly) |
| `spoke-okn` | Disease–gene associations (`ASSOCIATES_DaG`), cancer expression (`EXPRESSEDIN_GeiD`), prognostic markers (`MARKER_POS_GmpD`, `MARKER_NEG_GmnD`) |

### SPARQL Query Notes

- spoke-genelab stores `factor_space_1/2` as `xsd:string` typed literals; plain literal matching (`= "Space Flight"`) fails — use `STR()` comparison: `FILTER(STR(?fs1) = "Space Flight")`
- `factors_1/2` are multi-valued properties (multiple RDF triples per assay node), producing cross-product rows in broad queries
- Differential expression edge properties use RDF reification: `?stmt rdf:subject ?assay ; rdf:predicate schema:MEASURED_DIFFERENTIAL_EXPRESSION_ASmMG ; rdf:object ?gene`
- spoke-okn gene nodes use NCBI Gene IDs as URIs (`http://www.ncbi.nlm.nih.gov/gene/{ID}`), making cross-graph joins straightforward once human orthologs are identified

---

*Created by [mcp-proto-okn](https://github.com/sbl-sdsc/mcp-proto-okn) 0.6.0 on 2026-04-06*

Model: claude-opus-4-6
